JP2018522041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018522041A5 JP2018522041A5 JP2018505476A JP2018505476A JP2018522041A5 JP 2018522041 A5 JP2018522041 A5 JP 2018522041A5 JP 2018505476 A JP2018505476 A JP 2018505476A JP 2018505476 A JP2018505476 A JP 2018505476A JP 2018522041 A5 JP2018522041 A5 JP 2018522041A5
- Authority
- JP
- Japan
- Prior art keywords
- brachyury
- yeast
- immunotherapy composition
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562200497P | 2015-08-03 | 2015-08-03 | |
| US62/200,497 | 2015-08-03 | ||
| PCT/US2016/044977 WO2017023840A1 (en) | 2015-08-03 | 2016-08-01 | Modified yeast-brachyury immunotherapeutic compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018522041A JP2018522041A (ja) | 2018-08-09 |
| JP2018522041A5 true JP2018522041A5 (enExample) | 2019-09-12 |
| JP6789283B2 JP6789283B2 (ja) | 2020-11-25 |
Family
ID=56618277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018505476A Active JP6789283B2 (ja) | 2015-08-03 | 2016-08-01 | 改変酵母−ブラキュリー免疫療法組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11065313B2 (enExample) |
| EP (1) | EP3331552B1 (enExample) |
| JP (1) | JP6789283B2 (enExample) |
| KR (1) | KR102833272B1 (enExample) |
| CN (1) | CN108348586B (enExample) |
| AU (1) | AU2016303525B2 (enExample) |
| CA (1) | CA2994272C (enExample) |
| HK (1) | HK1249431A1 (enExample) |
| IL (1) | IL257208B (enExample) |
| TW (1) | TWI748957B (enExample) |
| WO (1) | WO2017023840A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2907560C (en) | 2013-03-19 | 2021-12-07 | Timothy C. Rodell | Yeast-based immunotherapy for chordoma |
| WO2015157639A1 (en) * | 2014-04-11 | 2015-10-15 | Globeimmune, Inc. | Yeast-based immunotherapy and type i interferon sensitivity |
| CA2994694A1 (en) | 2015-08-03 | 2017-02-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use |
| WO2019222073A1 (en) * | 2018-05-15 | 2019-11-21 | Globeimmune, Inc. | Lysates of recombinant yeast for inducing cellular immune responses |
| US20220023348A1 (en) | 2018-11-28 | 2022-01-27 | Forty Seven, Inc. | Genetically modified hspcs resistant to ablation regime |
| WO2022187963A1 (en) * | 2021-03-10 | 2022-09-15 | Provincial Health Services Authority | Immunotherapy agents targeting brachyury and methods of using same |
| WO2023172922A1 (en) * | 2022-03-08 | 2023-09-14 | Immunitybio, Inc. | Intratumorally injected yeast vaccine |
| EP4516807A1 (en) | 2023-08-28 | 2025-03-05 | Consorcio Centro de Investigación Biomédica en Red | Compositions for use in a method of providing improved hematopoietic stem cell engraftment |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2486400B1 (fr) | 1980-07-09 | 1986-05-30 | Univablot | Medicaments a base de levures ou de leurs extraits insolubles |
| NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| US4775622A (en) | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
| US5310654A (en) | 1985-07-31 | 1994-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining virulence of Yersinia |
| US5234830A (en) | 1988-02-03 | 1993-08-10 | Suntory Limited | DNA encoding a KEX2 endoprotease without a C-terminal hydrophobic region |
| IL95019A0 (en) | 1989-08-09 | 1991-06-10 | Mycogen Corp | Process for encapsulation of biologicals |
| US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| US5830463A (en) | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US5858378A (en) | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| WO1999018980A1 (en) | 1997-10-10 | 1999-04-22 | Meyer Pharmaceuticals, Llc | Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
| US5948646A (en) | 1997-12-11 | 1999-09-07 | Fordham University | Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes |
| US20020044948A1 (en) | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| JP2004527450A (ja) | 2000-04-06 | 2004-09-09 | シーア ファーマスーティカルズ エルエルシー | 微生物送達システム |
| AU2002225681A1 (en) | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| US7439042B2 (en) | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| CA2898163C (en) | 2002-12-16 | 2016-10-11 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| US20060009404A1 (en) | 2004-07-09 | 2006-01-12 | Williams Jason R | Tumor ablation in combination with pharmaceutical compositions |
| EP2371381A3 (en) | 2005-07-11 | 2012-07-18 | Globeimmune, Inc. | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| EP2468296A3 (en) | 2006-02-02 | 2013-12-04 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
| EP2004666B1 (en) | 2006-03-27 | 2014-09-03 | Globeimmune, Inc. | Ras mutation and compositions and methods related thereto |
| SG10201405420QA (en) | 2007-02-02 | 2014-10-30 | Globeimmune Inc | Methods for producing yeast-based vaccines |
| CA2678404C (en) * | 2007-02-28 | 2019-03-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Brachyury polypeptides and methods for use |
| RU2505313C2 (ru) | 2007-03-19 | 2014-01-27 | Глоубиммьюн, Инк. | Композиции и способы направленного устранения мутационного ускользания в направленной терапии рака |
| WO2009042642A2 (en) * | 2007-09-24 | 2009-04-02 | President And Fellows Of Harvard College | Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer |
| EP2331125A4 (en) | 2008-09-19 | 2013-03-27 | Globeimmune Inc | IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS |
| WO2010065626A1 (en) | 2008-12-02 | 2010-06-10 | Globeimmune, Inc. | Genotyping tools, methods and kits |
| US10383924B2 (en) * | 2009-04-17 | 2019-08-20 | Globeimmune, Inc. | Combination immunotherapy compositions against cancer and methods |
| EP2477647B1 (en) | 2009-09-14 | 2016-01-13 | The Regents of the University of Colorado | Modulation of yeast-based immunotherapy products and responses |
| WO2011115914A1 (en) | 2010-03-14 | 2011-09-22 | Globeimmune, Inc. | Pharmacogenomic and response-guided treatment of infectious disease using yeast-based immunotherapy |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| WO2012019127A2 (en) | 2010-08-05 | 2012-02-09 | The Regents Of The University Of Colorado | Combination yeast-based immunotherapy and arginine therapy for the treatment of myeloid-derived supressor cell-associated diseases |
| US9254320B2 (en) | 2010-12-17 | 2016-02-09 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| US8877205B2 (en) | 2011-02-12 | 2014-11-04 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis B infection |
| KR102046449B1 (ko) | 2011-03-17 | 2019-11-19 | 글로브이뮨 | 효모-브라큐리 면역요법 조성물 |
| EP2720716B1 (en) | 2011-06-14 | 2018-03-21 | Globeimmune, Inc. | Immunotherapeutic compositions for the treatment or prevention of hepatitis delta virus infection |
| WO2013025972A1 (en) * | 2011-08-17 | 2013-02-21 | Globeimmune, Inc. | Yeast-muc1 immunotherapeutic compositions and uses thereof |
| CA2907560C (en) | 2013-03-19 | 2021-12-07 | Timothy C. Rodell | Yeast-based immunotherapy for chordoma |
-
2016
- 2016-08-01 CA CA2994272A patent/CA2994272C/en active Active
- 2016-08-01 CN CN201680056316.XA patent/CN108348586B/zh active Active
- 2016-08-01 HK HK18109071.3A patent/HK1249431A1/zh unknown
- 2016-08-01 EP EP16750335.8A patent/EP3331552B1/en active Active
- 2016-08-01 KR KR1020187006157A patent/KR102833272B1/ko active Active
- 2016-08-01 AU AU2016303525A patent/AU2016303525B2/en active Active
- 2016-08-01 JP JP2018505476A patent/JP6789283B2/ja active Active
- 2016-08-01 WO PCT/US2016/044977 patent/WO2017023840A1/en not_active Ceased
- 2016-08-01 TW TW105124349A patent/TWI748957B/zh active
- 2016-08-01 US US15/749,832 patent/US11065313B2/en active Active
-
2018
- 2018-01-29 IL IL257208A patent/IL257208B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018522041A5 (enExample) | ||
| Zuo et al. | An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade | |
| TWI704226B (zh) | 重組溶瘤病毒組合物及其用途 | |
| JP7564572B2 (ja) | 単離された組換え体腫瘍溶解性ワクシニアウイルスとｎｋ細胞を含む治療薬、その使用およびそれを適用したキット | |
| JP2018535668A5 (enExample) | ||
| Francis et al. | Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer | |
| JP2014509595A5 (enExample) | ||
| CN101591646B (zh) | 一种治疗人宫颈癌的树突状细胞疫苗 | |
| RU2019132253A (ru) | Новая днк-вакцина, нацеленная на pd-l1, для иммунотерапии рака | |
| JP2019512020A5 (enExample) | ||
| JP2014139185A5 (enExample) | ||
| JP2020511139A5 (enExample) | ||
| CN105031630A (zh) | 同时分泌pd-1中和抗体和gm-csf因子的肿瘤细胞疫苗及其制备方法 | |
| Molinelli et al. | Biologic therapy in psoriasis (Part II): efficacy and safety of new treatment targeting IL23/IL-17 pathways | |
| JP2015000064A5 (enExample) | ||
| CN105462975A (zh) | 一种特异性抑制ctgf基因表达的小干扰rna及其应用 | |
| Xue et al. | Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes | |
| JP2014534262A5 (enExample) | ||
| CN113425856B (zh) | 一种含有基因修饰的溶瘤病毒的药物组合物及其在治疗癌症的用途 | |
| CN101050470A (zh) | 携带c57bl/6鼠端粒酶逆转录酶的重组腺病毒载体 | |
| CN104800204A (zh) | 桑辛素抗肿瘤用途 | |
| CN105462976A (zh) | 一种特异性抑制twist1基因表达的小干扰rna及其应用 | |
| Bakacs | Turning self cancer cells into nonself by viral xenogenization | |
| KR20220079799A (ko) | 예방접종 및 질환 요법을 위한 자가유래 유도 만능 줄기 세포와의 폭스바이러스의 용도 | |
| Iyer et al. | Molecular insights and promise of oncolytic virus based immunotherapy |